After Acticon Approval, AMS Looks To Biodegradable Stent For BPH
This article was originally published in The Gray Sheet
American Medical Systems, following the Dec. 18 PMA approval of its Acticon neosphincter for severe fecal incontinence, says it will focus development efforts going forward on the BioFlow biodegradable stent for benign prostatic hyperplasia
You may also be interested in...
Curon Medical's 12 sales reps will market the Secca system for the treatment of fecal incontinence. FDA 510(k) clearance was announced March 25
Office of New Drugs Director Peter Stein said in an interview that a large amount of coronavirus-related work is arriving at the FDA, but so far staff are keeping up.